Session » Genetics, Genomics and Proteomics Poster II

Date: Monday, November 9, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1263

Applications of Protein Microarray for Saliva Diagnostics in Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 1254

Deciphering the Immunome of Clinically Effective Immune Tolerization in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1260

Differential DNA Methylation and Reduced Expression of Transcription Factors in Human OA Cartilage

9:00AM-11:00AM: Abstract Number: 1245

Differential DNA Methylation Associated with Lupus Nephritis Shows Enrichment in Genes Involved in Regulation of TH2 Differentiation and Renal Development

9:00AM-11:00AM: Abstract Number: 1249

Differential Expression of SLE Susceptibility Genes By Interferon-Alpha and the HLA-DRB1*03:01 Haplotype in Ex Vivo B Cells

9:00AM-11:00AM: Abstract Number: 1248

Discovery of Novel Serum Biomarkers for Osteoarthritis Using Affinity Proteomics

9:00AM-11:00AM: Abstract Number: 1250

DNA Methylation and Its Relation to Immunological Phenotypes in Peripheral Blood: A Study of Anti-CCP Antibody Positivity from a Population-Based Pool

9:00AM-11:00AM: Abstract Number: 1262

Epigenome-Wide DNA Methylation Patterns Associated with Fatigue in Primary Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1244

Extracellular MicroRNAs in Synovial Fluid Reveal a Marked Proliferative Signature in Patients with Antibiotic-Refractory Lyme Arthritis

9:00AM-11:00AM: Abstract Number: 1256

Gas Chromatography/Time-of-Flight-Mass Spectrometry-Based Metabolomic Profiling in Cultured Fibroblast-like Synoviocytes from Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1246

Gene Expression Analysis of Adult Onset Still’s Disease and Systemic Juvenile Idiopathic Arthritis Suggest a Single Disease Continuum

9:00AM-11:00AM: Abstract Number: 1265

Genetic and Epigenetic Mapping of Very Early RA Synovial Fibroblasts

9:00AM-11:00AM: Abstract Number: 1255

Genome-Wide DNA Methylation Patterns in CD4+ T Reveal Significant Contribution of DNA Methylation to Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1257

Genome-Wide DNA Methylation Signatures of Salivary Gland Inflammation in Sjögren’s Syndrome

9:00AM-11:00AM: Abstract Number: 1242

Germ Line DNA Methylation Profiling Provides Novel Insights into the Parent-of-Origin Effect in Psoriatic Disease

9:00AM-11:00AM: Abstract Number: 1241

Identification and Validation of Diagnostic and Activity Urinary Metabolomic Biomarkers in Immune-Mediated Inflammatory Diseases

9:00AM-11:00AM: Abstract Number: 1253

Identification and Validation of Novel Putative Salivary Proteomic Biomarkers in Sjögren’s Syndrome and Different Disease Subsets

9:00AM-11:00AM: Abstract Number: 1258

Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed By Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract

9:00AM-11:00AM: Abstract Number: 1243

Identification of the Gene Expression Signatures Predicting the Responses to Three Biologics (infliximab, tocilizumab, and abatacept) in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1247

Methylation Analysis of HLA-B Locus in Familial Behçet Syndrome

9:00AM-11:00AM: Abstract Number: 1261

Molecular Analysis of Vascular Smooth Muscle Cells from Patients with Giant Cell Arteritis: Targeting Endothelin-1 Receptor to Control Proliferation

9:00AM-11:00AM: Abstract Number: 1251

Physiological Evidence for Diversification of the IFNα- or IFNβ-Mediated Response Programs in Different Autoimmune Diseases

9:00AM-11:00AM: Abstract Number: 1264

Residential Proximity to Highways, DNA Methylation and Systemic Lupus Erythematosus

9:00AM-11:00AM: Abstract Number: 1252

Serum Biomarkers Associated with Disease Activity and Response to Ustekinumab in Patients with Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1239

Significant Impact of Microrna-Target Gene Networks on the Genetics of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1240

Systematic Protein-Protein Interaction and Pathway Analyses in the Idiopathic Inflammatory Myopathies

9:00AM-11:00AM: Abstract Number: 1259

Verification of Haptoglobin and Von Willebrand Factor As Potential Biomarkers of Knee Osteoarthritis Using a Targeted Proteomics Approach in Serum

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].